Natriuretic Peptides in Heart Valve Disease

Overview

Journal Heart

Date 2005 Oct 28

PMID 16251227

Citations 4

Authors

S G Ray

Affiliations

Soon will be listed here.

Abstract

Synthesis and release of B-type natriuretic peptide (BNP) are increased in heart failure, and plasma concentrations provide important therapeutic and prognostic information. Recent studies have shown that BNP concentrations are also increased with disease of the mitral and aortic valves. The extent of the increase is broadly related to the severity of the valve abnormality and the degree of consequent cardiac remodelling. BNP concentrations appear to relate to prognosis in these patients and might have a role in identifying suitable candidates for cardiac surgery. This paper reviews the current literature and identifies areas where further research is required if assessment of BNP is to be of practical use.

Citing Articles

Severe Aortic Valve Stenosis: Symptoms, Biochemical Markers, and Global Longitudinal Strain.

Bottaro G, Zappulla P, Deste W, Fama F, Agnello F, Trovato D J Cardiovasc Echogr. 2021; 30(3):154-161.

PMID: 33447506 PMC: 7799072. DOI: 10.4103/jcecho.jcecho_13_20.

Hemoconcentration is a valuable predictor of prognosis in patients with acute heart failure.

Yan Q, Chen S Exp Ther Med. 2020; 19(4):2792-2798.

PMID: 32256762 PMC: 7086159. DOI: 10.3892/etm.2020.8515.

MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac Remodeling.

Oury C, Servais L, Bouznad N, Hego A, Nchimi A, Lancellotti P Int J Mol Sci. 2016; 17(7).

PMID: 27420053 PMC: 4964495. DOI: 10.3390/ijms17071120.

Natriuretic peptides in cardiovascular diseases: current use and perspectives.

Volpe M, Rubattu S, Burnett Jr J Eur Heart J. 2013; 35(7):419-25.

PMID: 24227810 PMC: 4023301. DOI: 10.1093/eurheartj/eht466.

References

Vanderheyden M, Goethals M, Verstreken S, De Bruyne B, Muller K, Van Schuerbeeck E . Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol. 2004; 44(12):2349-54. DOI: 10.1016/j.jacc.2004.09.038. View

Enriquez-Sarano M, Avierinos J, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V . Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005; 352(9):875-83. DOI: 10.1056/NEJMoa041451. View

Gerber I, Legget M, West T, Richards A, Stewart R . Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol. 2005; 95(7):898-901. DOI: 10.1016/j.amjcard.2004.11.053. View

Detaint D, Messika-Zeitoun D, Avierinos J, Scott C, Chen H, Burnett Jr J . B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation. 2005; 111(18):2391-7. DOI: 10.1161/01.CIR.0000164269.80908.9D. View

Das P, Rimington H, Chambers J . Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005; 26(13):1309-13. DOI: 10.1093/eurheartj/ehi250. View

Talwar S, Squire I, Davies J, Barnett D, Ng L . Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J. 1999; 20(23):1736-44. DOI: 10.1053/euhj.1999.1694. View

Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S . Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation. 2000; 102(25):3074-9. DOI: 10.1161/01.cir.102.25.3074. View

Talwar S, Downie P, Squire I, Davies J, Barnett D, Ng L . Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail. 2001; 3(1):15-9. DOI: 10.1016/s1388-9842(00)00074-x. View

Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjornerheim R, Endresen K . Natriuretic peptides in patients with aortic stenosis. Am Heart J. 2001; 142(4):725-32. DOI: 10.1067/mhj.2001.117131. View

10.

Qi W, Mathisen P, Kjekshus J, Simonsen S, Endresen K, Bjornerheim R . The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis. Clin Cardiol. 2002; 25(4):174-80. PMC: 6654173. DOI: 10.1002/clc.4960250408. View

11.

Gerber I, Stewart R, Legget M, West T, French R, Sutton T . Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 2003; 107(14):1884-90. DOI: 10.1161/01.CIR.0000060533.79248.0C. View

12.

Fukuda N, Shinohara H, Sakabe K, Nada T, Tamura Y . Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract. J Heart Valve Dis. 2003; 12(3):333-40. View

13.

Sutton T, Stewart R, Gerber I, West T, Richards A, Yandle T . Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol. 2003; 41(12):2280-7. DOI: 10.1016/s0735-1097(03)00486-8. View

14.

Gerber I, Stewart R, French J, Legget M, Greaves S, West T . Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. Am J Cardiol. 2003; 92(6):755-8. DOI: 10.1016/s0002-9149(03)00849-x. View

15.

Berendes E, Schmidt C, Van Aken H, Grosse Hartlage M, Rothenburger M, Wirtz S . A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg. 2003; 98(1):11-19. DOI: 10.1213/01.ANE.0000093249.35075.F1. View

16.

Tharaux P, Dussaule J, Vahanian A, Acar J, Ardaillou R . Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy. Clin Sci (Lond). 1994; 87(6):671-7. DOI: 10.1042/cs0870671. View

17.

Nakamura M, Kawata Y, Yoshida H, Arakawa N, Koeda T, Ichikawa T . Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis. Am Heart J. 1992; 124(5):1283-8. DOI: 10.1016/0002-8703(92)90413-p. View

18.

Hung J, Fu M, Cherng W, Inoue K, Tsai R, Ishibashi M . Rapid fall in elevated plasma atrial natriuretic peptide levels after successful catheter balloon valvuloplasty of mitral stenosis. Am Heart J. 1989; 117(2):381-5. DOI: 10.1016/0002-8703(89)90783-7. View

19.

Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V . Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol. 2004; 94(6):740-5. DOI: 10.1016/j.amjcard.2004.05.055. View

20.

Eimer M, Ekery D, Rigolin V, Bonow R, Carnethon M, Cotts W . Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. Am J Cardiol. 2004; 94(5):676-8. DOI: 10.1016/j.amjcard.2004.05.043. View